NMRA
Income statement / Annual
Last year (2023), Neumora Therapeutics, Inc. Common Stock's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Neumora Therapeutics, Inc. Common Stock's net income was -$235.93 M.
See Neumora Therapeutics, Inc. Common Stock,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$668,000.00 |
$2.70 M |
$1.55 M |
$0.00 |
| Gross Profit |
-$668,000.00 |
-$2.70 M |
-$1.55 M |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$142.72 M
|
$104.75 M
|
$212.78 M
|
$87.13 M
|
| General & Administrative
Expenses |
$45.48 M
|
$31.12 M
|
$24.55 M
|
$8.39 M
|
| Selling & Marketing
Expenses |
-$668,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$44.81 M
|
$31.12 M
|
$24.55 M
|
$8.39 M
|
| Other Expenses |
$0.00 |
$405,000.00 |
$11,000.00 |
-$3.75 M |
| Operating Expenses |
$187.53 M |
$135.87 M |
$237.32 M |
$95.52 M |
| Cost And Expenses |
$188.19 M |
$135.87 M |
$237.32 M |
$95.52 M |
| Interest Income |
$16.61 M |
$4.56 M |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$668,000.00
|
$2.70 M
|
$1.55 M
|
$105,000.00
|
| EBITDA |
-$187.53 M
|
-$135.28 M
|
-$236.79 M
|
-$95.41 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$47.46 M
|
$4.97 M
|
$11,000.00
|
-$3.75 M
|
| Income Before Tax |
-$235.66 M |
-$130.90 M |
-$237.31 M |
-$99.27 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$268,000.00 |
-$4.56 M |
$301,442.00 |
-$101,297.00 |
| Net Income |
-$235.93 M |
-$130.90 M |
-$237.31 M |
-$99.27 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
| EPS |
-1.49 |
-0.86 |
-1.56 |
-0.65 |
| EPS Diluted |
-1.49 |
-0.86 |
-1.56 |
-0.65 |
| Weighted Average Shares
Out |
$158.83 M
|
$151.95 M
|
$151.95 M
|
$151.95 M
|
| Weighted Average Shares
Out Diluted |
$158.83 M
|
$151.95 M
|
$151.95 M
|
$151.95 M
|
| Link |
|
|
|
|
